Ed Cleator

1.4k total citations
39 papers, 998 citations indexed

About

Ed Cleator is a scholar working on Organic Chemistry, Molecular Biology and Biotechnology. According to data from OpenAlex, Ed Cleator has authored 39 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Organic Chemistry, 15 papers in Molecular Biology and 6 papers in Biotechnology. Recurrent topics in Ed Cleator's work include Synthetic Organic Chemistry Methods (11 papers), Chemical Synthesis and Analysis (8 papers) and Marine Sponges and Natural Products (6 papers). Ed Cleator is often cited by papers focused on Synthetic Organic Chemistry Methods (11 papers), Chemical Synthesis and Analysis (8 papers) and Marine Sponges and Natural Products (6 papers). Ed Cleator collaborates with scholars based in United Kingdom, United States and Belgium. Ed Cleator's co-authors include Steven V. Ley, Carl A. Baxter, Peter R. Hewitt, Karel M. J. Brands, Debra J. Wallace, Robert A. Reamer, Martin D. Smith, Neil A. Strotman, Gavin W. Stewart and David J. Tapolczay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Communications.

In The Last Decade

Ed Cleator

38 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ed Cleator United Kingdom 17 777 318 154 92 78 39 998
Helena M. C. Ferraz Brazil 19 858 1.1× 173 0.5× 83 0.5× 89 1.0× 64 0.8× 72 1.0k
Hidetsura Cho Japan 16 971 1.2× 376 1.2× 93 0.6× 73 0.8× 105 1.3× 54 1.2k
Mohamed Abarbri France 21 1.3k 1.7× 172 0.5× 96 0.6× 66 0.7× 85 1.1× 104 1.5k
G. LHOMMET France 23 1.4k 1.8× 312 1.0× 101 0.7× 51 0.6× 61 0.8× 102 1.5k
Luigi Pinna Italy 28 1.3k 1.7× 413 1.3× 282 1.8× 64 0.7× 69 0.9× 51 1.5k
Takahiko Taniguchi Japan 22 1.1k 1.4× 649 2.0× 115 0.7× 89 1.0× 181 2.3× 78 1.5k
Núria Llor Spain 21 1.2k 1.5× 314 1.0× 109 0.7× 46 0.5× 58 0.7× 61 1.3k
Simona Sputore Italy 5 755 1.0× 288 0.9× 93 0.6× 121 1.3× 104 1.3× 6 956
Tomoyuki Esumi Japan 23 984 1.3× 538 1.7× 140 0.9× 85 0.9× 148 1.9× 52 1.4k
Delphine Joseph France 18 946 1.2× 275 0.9× 134 0.9× 53 0.6× 124 1.6× 64 1.3k

Countries citing papers authored by Ed Cleator

Since Specialization
Citations

This map shows the geographic impact of Ed Cleator's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Cleator with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Cleator more than expected).

Fields of papers citing papers by Ed Cleator

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Cleator. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Cleator. The network helps show where Ed Cleator may publish in the future.

Co-authorship network of co-authors of Ed Cleator

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Cleator. A scholar is included among the top collaborators of Ed Cleator based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Cleator. Ed Cleator is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bueken, Bart, et al.. (2025). Development of a Convergent and Scalable Synthetic Route to Long-Acting RSV Inhibitor JNJ-7950. Organic Process Research & Development. 29(4). 1036–1047.
2.
Maddess, Matthew L., Ed Cleator, Mariko Morimoto, et al.. (2024). Process Development of a Tricyclic Diazepine-Based IDH1 Mutant Inhibitor. Organic Process Research & Development. 28(6). 2343–2354. 2 indexed citations
3.
Jouffroy, Matthieu, et al.. (2023). Pd/C Catalyzed Dehalogenation of (Hetero)aryls Using Triethylsilane as Hydrogen Donor. Synthesis. 55(9). 1394–1400. 1 indexed citations
4.
Maddess, Matthew L., Ed Cleator, Mariko Morimoto, et al.. (2021). Development of a Stereoselective Synthesis of (1R,4R)- and (1S,4S)-2-Oxa-5-azabicyclo[2.2.2]octane. Organic Process Research & Development. 26(3). 640–647. 6 indexed citations
5.
Cleator, Ed, et al.. (2021). High-Throughput Experimentation Enabling Rapid Process Optimization of an RSV Drug Candidate. Organic Process Research & Development. 26(3). 976–986. 4 indexed citations
6.
Chung, Cheol K., Ed Cleator, Aaron M. Dumas, et al.. (2016). A Synthesis of a Spirocyclic Macrocyclic Protease Inhibitor for the Treatment of Hepatitis C. Organic Letters. 18(6). 1394–1397. 10 indexed citations
7.
Maddess, Matthew L., Jeremy P. Scott, Carl A. Baxter, et al.. (2014). Enantioselective Synthesis of a Highly Substituted Tetrahydrofluorene Derivative as a Potent and Selective Estrogen Receptor Beta Agonist. Organic Process Research & Development. 18(4). 528–538. 11 indexed citations
8.
Cleator, Ed, Jeremy P. Scott, Matthew M. Bio, et al.. (2013). Process Development and Multikilogram-Scale Synthesis of a TRPV1 Antagonist. Organic Process Research & Development. 17(12). 1561–1567. 7 indexed citations
9.
Xu, Feng, John Y. L. Chung, Zhuqing Liu, et al.. (2013). Asymmetric Synthesis of cis-2,5-Disubstituted Pyrrolidine, the Core Scaffold of β3-AR Agonists. Organic Letters. 15(6). 1342–1345. 41 indexed citations
10.
Ruck, Rebecca T., Mark A. Huffman, Gavin W. Stewart, et al.. (2012). Route Development and Multikilogram GMP Delivery of a Somatostatin Receptor Antagonist. Organic Process Research & Development. 16(8). 1329–1337. 8 indexed citations
11.
Kyle, Andrew F., et al.. (2011). Total synthesis of (−)-nakadomarin A. Chemical Communications. 47(36). 10037–10037. 63 indexed citations
12.
Baxter, Carl A., Ed Cleator, Karel M. J. Brands, et al.. (2011). The First Large-Scale Synthesis of MK-4305: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Disorder. Organic Process Research & Development. 15(2). 367–375. 78 indexed citations
13.
Baxter, Carl A., et al.. (2010). A Novel Approach to 3-Methylindoles by a Heck/Cyclization/Isomerization Process. Organic Letters. 12(4). 668–671. 28 indexed citations
14.
O’Neil, Ian A., et al.. (2007). The synthesis of functionalised chiral bicyclic lactam and lactone N-oxides using a tandem Cope elimination/reverse Cope elimination protocol. Tetrahedron Letters. 48(10). 1683–1686. 10 indexed citations
15.
Andrews, Stephen P., Matthew Ball, Ed Cleator, et al.. (2007). Total Synthesis of Five Thapsigargins: Guaianolide Natural Products Exhibiting Sub‐Nanomolar SERCA Inhibition. Chemistry - A European Journal. 13(20). 5688–5712. 74 indexed citations
16.
Bio, Matthew M., Karel M. J. Brands, Ed Cleator, et al.. (2007). A Practical and Scaleable Synthesis of 1R,5S-Bicyclo[3.1.0]hexan-2-one:  The Development of a Catalytic Lithium 2,2,6,6-Tetramethylpiperidide (LTMP) Mediated Intramolecular Cyclopropanation of (R)-1,2-Epoxyhex-5-ene. Organic Process Research & Development. 11(3). 637–641. 12 indexed citations
17.
Hewitt, Peter R., Ed Cleator, & Steven V. Ley. (2004). A concise total synthesis of (+)-okaramine C. Organic & Biomolecular Chemistry. 2(17). 2415–2415. 68 indexed citations
18.
19.
20.
Ley, Steven V., Ed Cleator, & Peter R. Hewitt. (2003). A rapid stereocontrolled synthesis of the 3a-hydroxy-pyrrolo[2,3-b]indole skeleton, a building block for 10b-hydroxy-pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones. Organic & Biomolecular Chemistry. 1(20). 3492–3494. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helena M. C. Ferraz Breakdown of academic impact, for papers by Hidetsura Cho Breakdown of academic impact, for papers by Mohamed Abarbri Breakdown of academic impact, for papers by G. LHOMMET Breakdown of academic impact, for papers by Luigi Pinna Breakdown of academic impact, for papers by Takahiko Taniguchi Breakdown of academic impact, for papers by Núria Llor Breakdown of academic impact, for papers by Simona Sputore Breakdown of academic impact, for papers by Tomoyuki Esumi Breakdown of academic impact, for papers by Delphine Joseph
Rankless by CCL
2026